Sanifit announces completion of enrollment in CaLIPSO – its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialsis

Aura Biosciences Presents Interim Phase 1b/2 Data at the American Society of Retina Specialists (ASRS) Annual Meeting

CorWave’s next-generation LVAD, Neptune, receives funding

Leading Prenatal App BabyscriptsTM Announces Acquisition of iBirthTM

BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors

Aura Biosciences Announces Update of Clinical Safety and Efficacy Data on Lead Candidate AU-011 for Choroidal Melanoma

Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board

BioClin Therapeutics, Inc.,Completes $50 Million Series B Financing with Addition of New Investors

CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support

Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease